61 related articles for article (PubMed ID: 26630774)
1. ANALYSIS OF INTERACTION OF PHENOLIC COMPOUNDS WITH CHOLECYSTOKININ SIGNALLING PATHWAY TO EXPLAIN EFFECTS ON REDUCING FOOD INTAKE.
Al Shukor N; Raes K; Van Camp J; Smagghe G
Commun Agric Appl Biol Sci; 2015; 80(1):177-82. PubMed ID: 26630774
[No Abstract] [Full Text] [Related]
2. Analysis of interaction of phenolic compounds with the cholecystokinin signaling pathway to explain effects on reducing food intake.
Al Shukor N; Raes K; Van Camp J; Smagghe G
Peptides; 2014 Mar; 53():225-31. PubMed ID: 24630973
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin directly inhibits neuronal activity of primary gonadotropin-releasing hormone cells through cholecystokinin-1 receptor.
Giacobini P; Wray S
Endocrinology; 2007 Jan; 148(1):63-71. PubMed ID: 17023535
[TBL] [Abstract][Full Text] [Related]
5. Use of multidimensional fluorescence resonance energy transfer to establish the orientation of cholecystokinin docked at the type A cholecystokinin receptor.
Harikumar KG; Gao F; Pinon DI; Miller LJ
Biochemistry; 2008 Sep; 47(36):9574-81. PubMed ID: 18700727
[TBL] [Abstract][Full Text] [Related]
6. Lack of ghrelin secretion in response to fasting in cholecystokinin-A (-1), -B (-2) receptor-deficient mice.
Sakurai C; Ohta M; Kanai S; Uematsu H; Funakoshi A; Miyasaka K
J Physiol Sci; 2006 Dec; 56(6):441-7. PubMed ID: 17134539
[TBL] [Abstract][Full Text] [Related]
7. The vagal afferent pathway does not play a major role in the induction of satiety by intestinal fatty acid in rats.
Ogawa N; Yamaguchi H; Shimbara T; Toshinai K; Kakutani M; Yonemori F; Nakazato M
Neurosci Lett; 2008 Mar; 433(1):38-42. PubMed ID: 18248897
[TBL] [Abstract][Full Text] [Related]
8. PKC-mediated inhibitory feedback of the cholecystokinin 1 receptor controls the shape of oscillatory Ca²⁺ signals.
Willems PH; Pahle J; Stalpers XL; Mugahid D; Nikolaew A; Koopman WJ; Kummer U
FEBS J; 2015 Jun; 282(11):2187-201. PubMed ID: 25779353
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
Wan S; Coleman FH; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.
Potter RM; Harikumar KG; Wu SV; Miller LJ
J Lipid Res; 2012 Jan; 53(1):137-48. PubMed ID: 22021636
[TBL] [Abstract][Full Text] [Related]
11. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
Bignon E; Bachy A; Boigegrain R; Brodin R; Cottineau M; Gully D; Herbert JM; Keane P; Labie C; Molimard JC; Olliero D; Oury-Donat F; Petereau C; Prabonnaud V; Rockstroh MP; Schaeffer P; Servant O; Thurneyssen O; Soubrié P; Pascal M; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
[TBL] [Abstract][Full Text] [Related]
12. Time-resolved quantitative analysis of CCK1 receptor-induced intracellular calcium increase.
Staljanssens D; De Vos WH; Willems P; Van Camp J; Smagghe G
Peptides; 2012 Mar; 34(1):219-25. PubMed ID: 21352882
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of β-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol.
Desai AJ; Dong M; Miller LJ
Clin Nutr; 2016 Dec; 35(6):1374-1379. PubMed ID: 27016394
[TBL] [Abstract][Full Text] [Related]
15. CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation.
Langmesser S; Cerezo-Guisado MI; Lorenzo MJ; Garcia-Marin LJ; Bragado MJ
J Cell Biochem; 2007 Mar; 100(4):851-64. PubMed ID: 17226751
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptor.
Harikumar KG; Cawston EE; Miller LJ
Assay Drug Dev Technol; 2011 Aug; 9(4):394-402. PubMed ID: 21395402
[TBL] [Abstract][Full Text] [Related]
17. Differential bile-pancreatic secretory effects of CCK-58 and CCK-8.
Reeve JR; Wu SV; Keire DA; Faull K; Chew P; Solomon TE; Green GM; Coskun T
Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G395-402. PubMed ID: 14604858
[TBL] [Abstract][Full Text] [Related]
18. Protein hydrolysates induce CCK release from enteroendocrine cells and act as partial agonists of the CCK1 receptor.
Foltz M; Ansems P; Schwarz J; Tasker MC; Lourbakos A; Gerhardt CC
J Agric Food Chem; 2008 Feb; 56(3):837-43. PubMed ID: 18211011
[TBL] [Abstract][Full Text] [Related]
19. Effect of lipopolysaccharide on expression and characterization of cholecystokinin receptors in rat pulmonary interstitial macrophages.
Xu SJ; Gao WJ; Cong B; Yao YX; Gu ZY
Acta Pharmacol Sin; 2004 Oct; 25(10):1347-53. PubMed ID: 15456538
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of phenolic 4,5-dihydroisoxazoles and 3-hydroxy ketones as estrogen receptor alpha and beta agonists.
Poutiainen PK; Venäläinen TA; Peräkylä M; Matilainen JM; Väisänen S; Honkakoski P; Laatikainen R; Pulkkinen JT
Bioorg Med Chem; 2010 May; 18(10):3437-47. PubMed ID: 20430632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
